Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Oral muscle-sparing small molecule therapies for obesity
Hawkhill Therapeutics is a pre-clinical biotechnology company developing oral, muscle-sparing therapeutics for obesity and metabolic health. Its programme targets a clinically…
NGS-based platform for off-target gene editing detection and characterisation
Broken String Biosciences is a Cambridge-based genomics company developing tools to improve the safety of cell and gene therapies. Its platform uses next-generation sequencing to…
ML-enabled nanoparticle delivery platform for targeted therapeutics
Vector Bioscience is a University of Cambridge spin-out developing a machine learning-enabled drug delivery platform based on metal-organic framework nanoparticles. The technology…
RNA therapeutics targeting cellular senescence and age-related disease
Senisca is a preclinical-stage biotechnology company developing oligonucleotide and small molecule therapeutics that reverse cellular senescence by restoring RNA splicing factor…
Proteomics and AI liquid biopsy for early lung cancer detection
Oxford Cancer Analytics is a biotechnology company developing blood-based diagnostic tests for early cancer detection using high-throughput circulating proteome analysis and…
Blood-based liquid biopsy for endothelial glycocalyx and microvascular health
Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer…
AI-driven combinatorial chemistry platform for next-generation RNA therapeutics
Eleven Therapeutics is a biotechnology company developing next-generation RNA therapeutics by combining combinatorial chemistry with artificial intelligence to map the vast…
AI-driven drug discovery targeting necrosis and age-related disease
LinkGevity is a preclinical-stage biotechnology company developing anti-necrotic therapeutics for age-related and degenerative diseases. Founded in 2023 and based at Babraham…
Tumour-activated peptide drug conjugates for targeted oncology
Avacta Therapeutics is a clinical-stage biotechnology company developing peptide drug conjugates designed to deliver toxic chemotherapy payloads selectively within the tumour…
Plant-based expression platform for recombinant protein production
Bright Biotech is a UK CDMO developing and applying a proprietary plant-based expression system for the production of recombinant proteins. Its platform uses chloroplast…
Novel peptide-based therapeutics and biomarkers for neurodegeneration
Neuro-Bio is a preclinical-stage biotechnology company developing a first-in-class therapeutic approach to Alzheimer's disease and related neurodegenerative disorders. Its…
Synthetic glucose-binding molecules for continuous glucose monitoring
Carbometrics Limited is a supramolecular chemistry biotech developing synthetic Glucose Binding Molecules (GBMs) for use in continuous glucose monitoring sensors and other…